Spectrum Pharmaceuticals (SPPI) Raises Buyback Plan to $100M

Spectrum Pharmaceuticals (Nasdaq: SPPI) announced that the Company’s Board of Directors has approved an increase in its stock repurchase program authorizing the repurchase of up to a total of $100 million of the Company's common stock. The Company was previously authorized to repurchase up to $25 million of its stock.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Mineros expands share repurchase program to $175 million
• SRX Global authorizes $20M share repurchase of up to 10M shares
• BlackRock increases quarterly share buyback plan to $550 million